What bioinformatics analyses are included in PAR-CLIP-seq data analysis?

The standard analysis pipeline includes raw data QC and filtering, reference genome alignment, peak calling, CIMS analysis (T-to-C transition-based crosslink site identification), peak annotation, motif discovery, signal distribution analysis (meta-gene profiles and heatmaps), GO/KEGG pathway enrichment, and generation of visualization files. For multi-condition experiments, differential binding analysis is also included.

Can PAR-CLIP-seq detect both RBP and miRNA target sites?

Yes. PAR-CLIP-seq performed on Argonaute (AGO) family proteins captures miRNA-mRNA target interactions. The T-to-C transitions at crosslink sites can map miRNA seed-binding positions, and enriched seed-complementary motifs in the target RNA validate the miRNA-dependent nature of the interaction.

PAR-CLIP-seq for RNA-Binding Protein Target Mapping

PAR-CLIP-seq (Photoactivatable Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation sequencing) incorporates 4-thiouridine (4SU) into nascent RNA in living cells, followed by 365 nm UV crosslinking to covalently trap RNA-protein interactions in situ. Immunoprecipitation of the RBP of interest, coupled with the diagnostic T-to-C transition at crosslinked nucleotides, enables transcriptome-wide identification of RBP binding sites at single-nucleotide resolution. CD Genomics provides end-to-end PAR-CLIP-seq support — from 4SU labeling and crosslinking through library preparation, sequencing, and CIMS-based bioinformatics analysis.

Key Highlights of Our PAR-CLIP-seq Service:

Single-Nucleotide Resolution: T-to-C diagnostic mutations pinpoint exact RBP crosslink sites, enabling base-pair-resolution binding site maps and precise motif discovery.
100–1,000× Crosslinking Efficiency: 4SU-mediated 365 nm UV-A crosslinking far outperforms standard 254 nm UV-C methods, capturing low-occupancy binding events that weaker approaches miss.
Built-In Specificity Control: CIMS analysis computationally separates T-to-C-marked true crosslink sites from non-specific background RNA, reducing false-positive binding calls.
End-to-End Bioinformatics: From raw read QC through CIMS analysis, motif discovery, and functional enrichment — a complete pipeline tailored to PAR-CLIP-seq data.

Get a Quote

PAR-CLIP-seq service overview showing 4SU incorporation into nascent RNA, 365 nm UV crosslinking to RBP, immunoprecipitation, and T-to-C transition-based single-nucleotide binding site identification

Technology

What Is PAR-CLIP-seq?

PAR-CLIP-seq (Photoactivatable Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation sequencing) is a transcriptome-wide method for mapping RNA-binding protein (RBP) interaction sites at single-nucleotide resolution. Developed by the Tuschl laboratory, the method exploits the photoactivatable nucleoside analog 4-thiouridine (4SU), which is incorporated into nascent RNA transcripts in living cells.

Upon irradiation with 365 nm UV-A light, 4SU-labeled RNA undergoes efficient covalent crosslinking to physically proximal RBPs — achieving 100- to 1,000-fold higher crosslinking efficiency than conventional 254 nm UV-C CLIP methods. The RBP-RNA complexes are then immunoprecipitated with an antibody against the RBP of interest, and the co-purified RNA is converted into a cDNA library for high-throughput sequencing.

The defining feature of PAR-CLIP-seq is the diagnostic T-to-C transition: during reverse transcription, the 4SU-crosslinked nucleotide causes the reverse transcriptase to incorporate guanosine (G) instead of adenosine (A) opposite the crosslinked uridine, generating a characteristic T-to-C mutation in the cDNA. By statistically identifying these transitions through CIMS (Crosslink-Induced Mutation Site) analysis, the exact crosslink position — and thus the precise RBP binding site — can be pinpointed at single-nucleotide resolution. This built-in mutation flag distinguishes true crosslink sites from background RNA co-purified during immunoprecipitation.

PAR-CLIP-seq technology principle showing 4SU incorporation into nascent RNA, 365 nm UV crosslinking to RBP, and T-to-C diagnostic mutation during reverse transcription for single-nucleotide crosslink site identification

Advantages

Key Advantages of PAR-CLIP-seq

Single-nucleotide resolution via T-to-C transitions. Unlike methods that rely on RNase footprinting or peak calling alone, PAR-CLIP-seq carries an internal validation mark — the T-to-C mutation at each crosslink site. CIMS analysis identifies these transitions statistically, separating true binding events from background RNA with high confidence. This yields base-pair-resolution binding site maps that support precise motif discovery and mutational analysis of RBP recognition elements.

High crosslinking efficiency. 4SU-mediated crosslinking with 365 nm UV-A achieves 100–1,000× higher efficiency than standard 254 nm UV-C crosslinking used in HITS-CLIP or iCLIP. Higher crosslinking yield means fewer input cells are consumed by the IP step, deeper coverage of the RBP's binding landscape, and more reproducible identification of low-occupancy binding sites that weaker crosslinking methods may miss.

Built-in specificity filter. The requirement for a T-to-C transition at the crosslink site acts as a stringent specificity filter. RNA fragments that co-purify non-specifically during immunoprecipitation lack the 4SU-induced mutation signature and are computationally distinguishable from bona fide crosslinked RNA. This reduces false-positive binding site calls and strengthens motif enrichment signals.

Workflow

PAR-CLIP-seq Workflow and Quality Control

The PAR-CLIP-seq workflow spans six stages, each with integrated quality control checkpoints. The complete process — from 4SU labeling of live cells to T-to-C transition analysis — is outlined below.

4SU Labeling. 4-thiouridine is added to live cell culture at a concentration of 100 μM. Cells are incubated to allow incorporation of 4SU into nascent RNA transcripts. QC: cell viability monitored by trypan blue staining; 4SU incorporation efficiency assessed by spectrophotometry of extracted RNA.
UV Crosslinking. Cells are irradiated with 365 nm UV-A light. The photoactivatable 4SU moiety forms covalent bonds with proximal RNA-binding proteins in situ, capturing direct and specific RNA-protein interactions. QC: crosslinking efficiency evaluated by SDS-PAGE and western blot for RBP-RNA complex detection.
Immunoprecipitation. Cells are lysed under denaturing or native conditions depending on the RBP, and the RBP of interest is immunoprecipitated using a specific antibody. Partial RNase digestion trims unprotected RNA, leaving only the RBP-protected fragments. QC: IP efficiency confirmed by western blot; RNase digestion conditions titrated per RBP.
RNA Isolation and cDNA Library Preparation. Co-purified RNA is isolated, dephosphorylated, and ligated to 3' and 5' adapters. Reverse transcription generates cDNA; the 4SU crosslinked nucleotide directs incorporation of G instead of A, creating the diagnostic T-to-C mutation. cDNA is PCR-amplified to generate the sequencing library. QC: library size distribution assessed; adapter dimer content evaluated.
High-Throughput Sequencing. Libraries are sequenced on an Illumina platform with paired-end reads. A shallow pilot run (10–20 million read pairs) is recommended before committing to full-depth sequencing to verify library complexity and T-to-C mutation rates. QC: Q30 scores, duplication rate, T-to-C transition frequency in reads.
CIMS Analysis and Binding Site Identification. Reads are aligned to the reference genome. T-to-C transitions are identified statistically using PARalyzer or CTK to call high-confidence crosslink sites. QC: CIMS signal-to-background ratio; motif enrichment assessed.

Sample

Sample Requirements for PAR-CLIP-seq

PAR-CLIP-seq requires live cultured cells capable of incorporating 4SU into nascent RNA. Sample quality and quantity directly affect crosslinking efficiency, library complexity, and the sensitivity of binding site detection.

Sample Parameter	Requirement	Notes
Sample type	Live cultured cells	4SU must be incorporated metabolically; pre-fixed or frozen cells are not compatible
Minimum cell input	≥3×10⁷ cells per sample	Higher input recommended for low-abundance RBPs or when IP efficiency is unknown
Cell viability	>90% by trypan blue or flow cytometry	Low viability compromises 4SU incorporation and increases non-specific background
4SU tolerance	Cell-line dependent; pilot test recommended	Some cell lines may show cytotoxicity at 100 μM 4SU; dose optimization may be required
Shipping	Live cells at appropriate culture density	Contact our project scientists for cell-type-specific shipping protocols before sample collection

4SU labeling checkpoints:

Confirm 4SU incorporation efficiency by spectrophotometric measurement of extracted total RNA before proceeding to crosslinking.
For new cell lines or RBPs not previously studied by PAR-CLIP, a small-scale pilot labeling experiment is recommended to verify 4SU incorporation and absence of cytotoxicity.

Bioinformatics

PAR-CLIP-seq Bioinformatics Analysis Pipeline

Raw PAR-CLIP-seq reads undergo a dedicated computational pipeline that integrates standard CLIP analysis with PAR-CLIP-specific CIMS-based crosslink site identification. The analysis produces binding site maps, enriched sequence motifs, and functional annotation of RBP target genes.

Raw Data QC and Filtering. Adapter trimming and removal of low-quality reads. QC metrics including per-base quality scores, GC content, and adapter content are reported.
Read Alignment. Filtered reads are aligned to the reference genome. PCR duplicates are removed. Multi-mapping reads are handled according to project-specific parameters.
Peak Calling and Binding Site Identification. Enriched binding regions are identified using CLIP-specific peak callers. For PAR-CLIP data, PARalyzer or CLIP Tool Kit (CTK) is employed to model the characteristic T-to-C transition pattern and call high-confidence crosslink-induced mutation sites (CIMS).
CIMS Analysis. T-to-C transitions at each genomic position are statistically evaluated against a background mutation model. Positions with significantly elevated T-to-C frequency are classified as crosslink-induced mutation sites, providing single-nucleotide resolution of RBP binding positions. This step is PAR-CLIP-specific and is not available for standard CLIP-seq data.
Peak Annotation. Binding sites are annotated relative to genomic features: 5' UTR, CDS, 3' UTR, introns, and intergenic regions. Distribution across transcript isoforms is reported.
Motif Analysis. Sequence motifs enriched at CIMS-defined binding sites are identified. Both primary motif and secondary motifs are reported. Motif enrichment is benchmarked against shuffled control sequences.
Signal Distribution Analysis. Meta-gene profiles show binding site enrichment patterns across gene features. Read density heatmaps centered on CIMS sites provide visual assessment of binding specificity.
GO and KEGG Enrichment. Target genes associated with binding sites are tested for enrichment of Gene Ontology terms and KEGG pathways, with multiple testing correction applied.
Visualization and Reporting. Genome browser-compatible coverage tracks, called peaks and CIMS sites, motif logos, heatmaps, and enrichment plots are provided in publication-ready formats.
Differential Binding Analysis. For experiments with multiple conditions or time points, differential binding between groups is assessed using statistical models applied to read counts at consensus binding sites, identifying condition-specific or treatment-responsive RBP targets.

For projects requiring multi-omics integration — for example, combining PAR-CLIP-seq binding maps with transcriptomic data to link RBP binding to expression changes — our team provides integrating RNA-seq and epigenomic data analysis support.

Demo

Representative PAR-CLIP-seq Data and Results

The composite figure below shows the standard analysis outputs delivered with each PAR-CLIP-seq project. The five panels cover the key analytical dimensions: genome browser tracks of read enrichment with T-to-C sites marked, sequence motif logos derived from high-confidence CIMS positions, meta-gene signal distribution across transcript features, CIMS mutation frequency analysis distinguishing true crosslink positions from background, and functional enrichment of target genes.

Representative PAR-CLIP-seq analysis outputs delivered with each project. (A) IGV browser tracks showing read enrichment with T-to-C mutation sites marked. (B) Enriched sequence motif identified at high-confidence CIMS positions. (C) Meta-gene signal distribution across transcript features. (D) CIMS T-to-C mutation frequency at crosslink positions vs. background. (E) GO/KEGG functional enrichment of RBP target genes.

Deliverables

Data Deliverables

Deliverable	Description
Raw sequencing data	Demultiplexed, adapter-trimmed paired-end reads with QC metrics
Alignment files	Reads aligned to reference genome with duplicate marking and alignment statistics
Peak calls and CIMS sites	Genomic coordinates of enriched binding regions and high-confidence crosslink-induced mutation sites with T-to-C frequency
Coverage tracks	Normalized read coverage tracks for genome browser visualization
Motif analysis	Enriched sequence motifs at CIMS-defined binding sites, with statistical significance
Signal distribution plots	Meta-gene profiles and heatmaps showing binding enrichment across transcript features
GO/KEGG enrichment	Functional enrichment analysis of RBP target genes with multiple testing correction
Differential binding (if applicable)	Differentially bound sites between experimental conditions with fold change and significance
Project report	Methods summary, QC metrics, complete analysis results, and figure legends

Applications

Applications of PAR-CLIP-seq in RNA Biology

PAR-CLIP-seq addresses a central question in post-transcriptional gene regulation: where does a given RBP bind across the transcriptome, and what sequence or structural features define its recognition elements?

De novo RBP Characterization

For RBPs without prior binding specificity data, PAR-CLIP-seq provides an unbiased, transcriptome-wide map of all interaction sites. The T-to-C mutation signature pinpoints binding positions, enabling motif discovery and binding site classification.

miRNA Target Identification

PAR-CLIP-seq of Argonaute (AGO) proteins captures miRNA-mRNA target interactions transcriptome-wide. For studies focused on miRNA target validation, RIP-qPCR validation provides a complementary approach for confirming individual miRNA-target interactions.

Dual DNA/RNA-Binding Protein Analysis

Proteins such as Sox2 and YY1 bind both DNA and RNA. PAR-CLIP-seq can separate the RNA-binding activity of these dual-function proteins from their DNA-binding roles, providing a transcriptome-wide view of their RNA interactome.

RBP Function in Disease

Identifying the RNA targets of disease-associated RBPs — including splicing factors, mRNA stability regulators, and translation control proteins — connects genetic mutations in RBPs to dysregulated post-transcriptional programs.

For studies comparing RBP binding with RNA expression or modification status, RIP-seq offers an antibody-based RNA co-immunoprecipitation approach, and ONT Direct RNA Sequencing provides native RNA analysis including base modification detection.

Case

Case Study: PAR-CLIP-seq Identifies PRRC2B as a Translational Regulator in Cell Cycle Progression

PAR-CLIP-seq Identifies PRRC2B as a Translational Regulator

Background: Post-transcriptional control — including RNA splicing, transport, modification, translation, and degradation — depends largely on RNA-binding proteins. However, many RBPs remain functionally uncharacterized. PRRC2B (Proline-Rich Coiled-Coil 2B) was identified as a candidate RBP without known RNA targets or biological function, motivating a systematic PAR-CLIP-seq investigation.

Methods: PAR-CLIP-seq was performed in HEK293T cells expressing PRRC2B. Cells were labeled with 4SU at 100 μM, crosslinked with 365 nm UV, and PRRC2B-RNA complexes were immunoprecipitated. cDNA libraries were sequenced and analyzed using PARalyzer for CIMS-based binding site identification. Motif enrichment analysis was performed using HOMER. Functional validation included ribosome profiling, polysome fractionation, and antisense oligonucleotide (ASO) blocking of PRRC2B-mRNA interactions.

Results: PAR-CLIP-seq identified transcriptome-wide PRRC2B binding sites enriched for CU- or GA-rich sequence motifs located near translation initiation codons. PRRC2B target mRNAs included cell cycle regulators such as CCND2 (cyclin D2) and oncogenes. PRRC2B was found to interact with translation initiation factors eIF3 and eIF4G2 in an RNA-independent manner. ASO-mediated disruption of the PRRC2B-CCND2 mRNA interaction inhibited G1/S cell cycle transition and reduced cell proliferation, demonstrating the functional significance of the PAR-CLIP-defined binding sites.

PAR-CLIP-seq identifies transcriptome-wide PRRC2B binding sites at CU- and GA-rich motifs near translation initiation codons in HEK293T cells. Source: Jiang et al., Nucleic Acids Research, 2023.

Conclusion: This study demonstrates how PAR-CLIP-seq can transform an uncharacterized RBP into a mechanistically understood post-transcriptional regulator. The nucleotide-resolution binding maps enabled by T-to-C transition analysis were essential for defining the PRRC2B recognition motif and identifying the specific mRNA targets — including CCND2 — whose translational regulation controls cell cycle progression.

Source: Jiang F, Hedaya OM, Khor E, et al. RNA binding protein PRRC2B mediates translation of specific mRNAs and regulates cell cycle progression. Nucleic Acids Research, 2023, 51(11):5831-5846.

Method Comparison

PAR-CLIP-seq vs eCLIP-seq vs iCLIP-seq: Method Comparison

Selecting the appropriate CLIP method for an RBP study depends on sample type, desired resolution, willingness to use radioactivity, and the importance of single-nucleotide crosslink site identification. The comparison below summarizes the key differentiating features.

Feature	PAR-CLIP-seq	eCLIP-seq	iCLIP-seq
Crosslinking method	365 nm UV-A + 4SU/6SG metabolic labeling	254 nm UV-C	254 nm UV-C
Resolution mechanism	T-to-C diagnostic mutation at crosslink site	Adaptor-based ligation (no circularization)	RT truncation at crosslink site
Resolution achieved	Single-nucleotide	High	Single-nucleotide
Crosslinking efficiency	100–1,000× higher than 254 nm UV-C	Standard UV-C efficiency	Standard UV-C efficiency
Radioisotope use	Yes (³²P labeling)	No	Yes (³²P labeling)
Sample requirement	Live cultured cells (4SU incorporation required)	Cells or tissue (live or crosslinked)	Cells or tissue
Minimum cell input	≥3×10⁷	Millions of cells	Millions of cells
Key advantage	T-to-C mutation pinpoints exact crosslink sites; highest crosslinking efficiency	No radioactivity; SMI controls improve specificity; ENCODE standard	True single-nucleotide resolution via RT stalling; no metabolic labeling needed
Key limitation	Limited to cells tolerant of 4SU; potential cytotoxicity	IP efficiency not visually trackable; lower crosslinking yield	Inefficient cDNA circularization; higher PCR duplicates
Best for	Nucleotide-resolution RBP binding site mapping in cell culture models	Large-scale RBP profiling; labs avoiding radioactivity	Single-nucleotide resolution without metabolic labeling

Selection guidance:

Choose eCLIP-seq if you need broad RBP profiling, want to avoid radioactivity, or are working with tissue samples where metabolic labeling is not feasible.
Choose PAR-CLIP-seq if single-nucleotide resolution is critical for your analysis (e.g., motif discovery, mutation analysis of binding sites) and you can work with cultured cells tolerant of 4SU.
Choose miCLIP-seq if you need single-nucleotide resolution from tissue samples or when metabolic labeling is not possible.

FAQ

Frequently Asked Questions (FAQ)

Q: What is PAR-CLIP-seq and how does it differ from standard CLIP-seq?

A: PAR-CLIP-seq is a variant of CLIP-seq that uses 4-thiouridine (4SU) metabolic labeling followed by 365 nm UV-A crosslinking, rather than standard 254 nm UV-C crosslinking. The 4SU incorporation enables 100–1,000× higher crosslinking efficiency and introduces a diagnostic T-to-C mutation at crosslink sites, which CIMS analysis uses to pinpoint RBP binding positions at single-nucleotide resolution — a feature not available with conventional CLIP-seq.

Q: What is the T-to-C transition and why is it important?

A: During reverse transcription of 4SU-crosslinked RNA, the modified uridine causes the reverse transcriptase to misincorporate guanosine (G) instead of adenosine (A), generating a T-to-C mutation in the cDNA at the exact crosslink position. CIMS analysis statistically identifies these mutations, distinguishing true crosslinked RNA from background and enabling single-nucleotide resolution binding site identification without relying solely on peak boundaries or RNase footprint patterns.

Q: How does PAR-CLIP-seq compare to eCLIP-seq and iCLIP-seq?

Q: What sample types are suitable for PAR-CLIP-seq?

Q: How many cells are needed for a PAR-CLIP-seq experiment?

Q: What bioinformatics analyses are included?

References

CD Genomics provides PAR-CLIP-seq services for research use only (RUO). Our services have not been validated for diagnostic or clinical decision-making. All service specifications and deliverable descriptions are subject to project-specific confirmation. Case study results shown are from published, peer-reviewed literature and do not represent data generated by CD Genomics unless explicitly stated.